Evidence map›Paper›PMID 31094677›Full record

ArticleeLife2019

Misfolded GPI-anchored proteins are escorted through the secretory pathway by ER-derived factors.

Eszter Zavodszky, Ramanujan S Hegde

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. New frontiers in quality control: the case of GPI-anchored proteins.Nature reviews. Molecular cell biology · 2023
    Article
  17. Genetic characterization of C. elegans TMED genes.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Article
  18. Article
  19. Dysregulated proteostasis network in neuronal diseases.Frontiers in cell and developmental biology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eszter ZavodszkyMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.ORCID 0000-0002-4123-8758
Ramanujan S HegdeMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.ORCID 0000-0001-8338-852X
MRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council MC_UP_A022_1007
6 · The paper itself

Abstract

We have used misfolded prion protein (PrP*) as a model to investigate how mammalian cells recognize and degrade misfolded GPI-anchored proteins. While most misfolded membrane proteins are degraded by proteasomes, misfolded GPI-anchored proteins are primarily degraded in lysosomes. Quantitative flow cytometry analysis showed that at least 85% of PrP* molecules transiently access the plasma membrane

Indexed as

Protein FoldingSecretory PathwayCell MembraneEndoplasmic ReticulumGlycosylphosphatidylinositolsGreen Fluorescent ProteinsHEK293 CellsHumansLysosomesPrionsProteolysisGlycosylphosphatidylinositolsGreen Fluorescent ProteinsPrionscell biologychaperoneendoplasmic reticulumnoneprotein degradationprotein quality controlprotein trafficking

Identifiers

PMID31094677
PMCPMC6541436
OpenAlexW2945949549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.